TREATMENT OF TUMORS USING SPECIFIC ANTI-L1 ANTIBODY

The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.

Saved in:
Bibliographic Details
Main Authors FRANK BREITLING, SUSANNE SEBENS, HEINER SCHÄFER, ACHIM KRÜGER, SANDRA LÜTTGAU, ULRICH MÖBIUS, GERHARD MOLDENHAUER, PETER ALTEVOGT, DANIELA KELM, SILKE BÄRREITER, YI LI
Format Patent
LanguageEnglish
Portuguese
Published 15.02.2018
Subjects
CHEMISTRY
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to the anti-L1 monoclonal antibody 9.3 as well as to related antibodies or binding molecules and well as to the uses thereof, especially in tumor treatment.
Bibliography:Application Number: PT20130000027T